DAVE:NASDAQDave Inc. Analysis
Data as of 2026-06-17 - not real-time
$285.84
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Dave Inc. is trading well above its 20‑day and 50‑day SMAs (≈269 and 255) and comfortably beneath the 200‑day SMA (218), indicating a strong bullish bias. The MACD histogram is positive (+2.46) and the signal line is bullish, while the RSI sits at a neutral 57, suggesting room for upside without immediate overbought pressure. Revenue is surging at 46.7% YoY with a high gross margin of 72% and operating margin above 38%, positioning the company as a high‑growth player in the fintech software space. Valuation metrics are mixed: a forward PE of 13.8 is well below the industry average PE of 37, yet the current price (~286) exceeds the DCF‑derived fair value of 238, implying a modest premium. The stock’s beta (> 2.4) and 30‑day volatility (> 65%) flag heightened market sensitivity, while volume trends are weakening, adding a liquidity caution. The Fear & Greed Index reads Extreme Greed, reflecting strong investor enthusiasm that could amplify price swings. Recent material news notes an insider sale and a strategic shift of ExtraCash receivables, which may signal capital allocation confidence but also introduces short‑term perception risk. Overall, the technical setup is bullish, fundamentals are robust, yet valuation premium and risk factors warrant careful positioning.
Investors should weigh the upside potential against the elevated volatility and liquidity concerns; a disciplined entry near support (~225) could capture upside toward the resistance zone around 319, while maintaining vigilance on macro‑risk and regulatory developments in the neobank sector.
Investors should weigh the upside potential against the elevated volatility and liquidity concerns; a disciplined entry near support (~225) could capture upside toward the resistance zone around 319, while maintaining vigilance on macro‑risk and regulatory developments in the neobank sector.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish technical indicators (price above SMAs, positive MACD)
- Support level around $225 offering downside cushion
- Current market sentiment of extreme greed driving short‑term demand
Medium Term
1–3 yearsNeutral
Model confidence: 8/10
Key Factors
- Strong revenue growth and high profit margins
- Valuation premium relative to DCF fair value
- Elevated beta and volatility suggesting price swings
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Sustained high‑growth trajectory in a expanding fintech niche
- Robust operating cash flow and improving free cash flow
- Strategic capital allocation moves reducing cost of capital
Key Metrics & Analysis
Financial Health
Revenue Growth46.70%
Profit Margin37.21%
P/E Ratio18.3
ROE111.59%
ROA32.00%
Debt/Equity131.62
P/B Ratio17.8
Op. Cash Flow$326.8M
Free Cash Flow$85.7M
Industry P/E37.0
Technical Analysis
TrendBullish
RSI56.9
Support$224.80
Resistance$318.66
MA 20$268.70
MA 50$255.02
MA 200$218.03
MACDBullish
VolumeDecreasing
Fear & Greed Index88.5
Valuation
Fair Value$238.20
Target Price$335.73
Upside/Downside17.45%
GradeFair
TypeGrowth
Risk Assessment
Beta2.45
Volatility65.94%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.